|
|
|||
| |||||||||||||||||||||||||||||||||||||||
Although it has many advantages, the institution-centered regulatory framework may not provide adequate protection of due process for accused investigators. Our view is that the current regulatory structure falls short of the optimal balance between
History of Federal Oversight
Due Process in Misconduct Proceedings Today
Comparisons with Hospital Credentialing and Billing Fraud
Striking a Balance
Conclusions
Source Information
From the Department of Health Policy and Management, Harvard School of Public Health (M.M.M., T.A.B.); the Department of Medicine, Harvard Medical School (T.A.B.); and Brigham and Women's Hospital (T.A.B.) all in Boston.
Address reprint requests to Dr. Brennan at Brigham and Women's Hospital, 75 Francis St., PBB4, Boston, MA 02115, or at tabrennan@partners.org.
This article has been cited by other articles:
HOME | SUBSCRIBE | SEARCH | CURRENT ISSUE | PAST ISSUES | COLLECTIONS | PRIVACY | HELP | beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved. |